4//SEC Filing
ASELAGE STEVE 4
Accession 0001209191-21-063591
CIK 0001438533other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 4:05 PM ET
Size
9.6 KB
Accession
0001209191-21-063591
Insider Transaction Report
Form 4
ASELAGE STEVE
Director
Transactions
- Sale
Common Stock
2021-11-05$26.23/sh−10,000$262,300→ 161,794 total - Exercise/Conversion
Common Stock
2021-11-05$16.23/sh+10,000$162,300→ 171,794 total - Exercise/Conversion
Employee stock option (right to buy)
2021-11-05−10,000→ 70,000 totalExercise: $16.23Exp: 2026-05-18→ Common Stock (10,000 underlying)
Holdings
- 19,500(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to an automatic trading plan adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]The shares are held in the name of the Aselage Family Trust.
- [F3]The stock option is fully vested and exercisable.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001221599
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 4:05 PM ET
- Size
- 9.6 KB